Loading…

Neuroprotective effects of ZL006 in Aβ1-42-treated neuronal cells

Amyloid beta (Aβ)-induced neurotoxicity and oxidative stress plays an important role in the pathogenesis of Alzheimer's disease (AD). ZL006 is shown to reduce over-produced nitric oxide and oxidative stress in ischemic stroke by interrupting the interaction of neuronal nitric oxide synthase and...

Full description

Saved in:
Bibliographic Details
Published in:Neural regeneration research 2020-12, Vol.15 (12), p.2296-2305
Main Authors: Tao, Wen-Yuan, Yu, Lin-Jie, Jiang, Su, Cao, Xiang, Chen, Jian, Bao, Xin-Yu, Li, Fei, Xu, Yun, Zhu, Xiao-Lei
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 2305
container_issue 12
container_start_page 2296
container_title Neural regeneration research
container_volume 15
creator Tao, Wen-Yuan
Yu, Lin-Jie
Jiang, Su
Cao, Xiang
Chen, Jian
Bao, Xin-Yu
Li, Fei
Xu, Yun
Zhu, Xiao-Lei
description Amyloid beta (Aβ)-induced neurotoxicity and oxidative stress plays an important role in the pathogenesis of Alzheimer's disease (AD). ZL006 is shown to reduce over-produced nitric oxide and oxidative stress in ischemic stroke by interrupting the interaction of neuronal nitric oxide synthase and postsynaptic density protein 95. However, few studies are reported on the role of ZL006 in AD. To investigate whether ZL006 exerted neuroprotective effects in AD, we used Aβ1-42 to treat primary cortical neurons and N2a neuroblastoma cells as an in vitro model of AD. Cortical neurons were incubated with ZL006 or dimethyl sulfoxide for 2 hours and treated with Aβ1-42 or NH3*H2O for another 24 hours. The results of cell counting Kit-8 (CCK-8) assay and calcein-acetoxymethylester/propidium iodide staining showed that ZL006 pretreatment rescued the neuronal death induced by Aβ1-42. Fluorescence and western blot assay were used to detect oxidative stress and apoptosis-related proteins in each group of cells. Results showed that ZL006 pretreatment decreased neuronal apoptosis and oxidative stress induced by Aβ1-42. The results of CCK8 assay showed that inhibition of Akt or NF-E2-related factor 2 (Nrf2) in cortical neurons abolished the protective effects of ZL006. Moreover, similar results were also observed in N2a neuroblastoma cells. ZL006 inhibited N2a cell death and oxidative stress induced by Aβ1-42, while inhibition of Akt or Nrf2 abolished the protective effect of ZL006. These results demonstrated that ZL006 reduced Aβ1-42-induced neuronal damage and oxidative stress, and the mechanisms might be associated with the activation of Akt/Nrf2/heme oxygenase-1 signaling pathways.
doi_str_mv 10.4103/1673-5374.285006
format article
fullrecord <record><control><sourceid>wanfang_jour_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_4c202693cf1541ea9f1cad71639ed9cf</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><wanfj_id>zgsjzsyj_e202012026</wanfj_id><doaj_id>oai_doaj_org_article_4c202693cf1541ea9f1cad71639ed9cf</doaj_id><sourcerecordid>zgsjzsyj_e202012026</sourcerecordid><originalsourceid>FETCH-LOGICAL-d475o-4a7dfee084a467fda82b962509f266377f00eb0a51a43b3c39890c4f0fdc46513</originalsourceid><addsrcrecordid>eNpVkU1v1DAQhi0EoqVw5xiJI0oZf8cXpLLio9KqXNoLF8vrjJekabzYSVftz-KH8JvwstuinmY0H8-8mpeQtxROBQX-gSrNa8m1OGWNBFDPyDFttKq1kc3zkj-0j8irnHsA2RjGX5IjzqQRINkx-XSBc4qbFCf0U3eLFYZQslzFUP1YFmTVjdXZn9-0FqyeEroJ22rc7YxuqDwOQ35NXgQ3ZHxziCfk6svny8W3evn96_nibFm3QstYC6fbgAiNcELp0LqGrYxiEkxgSnGtAwCuwEnqBF9xz01jwIsAofVCScpPyPme20bX203qbly6s9F19l8hprV1aer8gFZ4BkwZ7gOVgqIzgXrXaqq4wdb4UFgf96zNvLrB1uM4JTc8gT7tjN1Pu463VmthhIICeL8HbN0Y3Li2fZxTeUm29-vc3-e73mLRAHQnpEy_O5xL8deMefo_zgTVRoExO-biwIzDhClfD_MWky0qrse4tRTsznT76Krdm24ZM8o--Mj_Am6hobA</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2417960990</pqid></control><display><type>article</type><title>Neuroprotective effects of ZL006 in Aβ1-42-treated neuronal cells</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Tao, Wen-Yuan ; Yu, Lin-Jie ; Jiang, Su ; Cao, Xiang ; Chen, Jian ; Bao, Xin-Yu ; Li, Fei ; Xu, Yun ; Zhu, Xiao-Lei</creator><creatorcontrib>Tao, Wen-Yuan ; Yu, Lin-Jie ; Jiang, Su ; Cao, Xiang ; Chen, Jian ; Bao, Xin-Yu ; Li, Fei ; Xu, Yun ; Zhu, Xiao-Lei</creatorcontrib><description>Amyloid beta (Aβ)-induced neurotoxicity and oxidative stress plays an important role in the pathogenesis of Alzheimer's disease (AD). ZL006 is shown to reduce over-produced nitric oxide and oxidative stress in ischemic stroke by interrupting the interaction of neuronal nitric oxide synthase and postsynaptic density protein 95. However, few studies are reported on the role of ZL006 in AD. To investigate whether ZL006 exerted neuroprotective effects in AD, we used Aβ1-42 to treat primary cortical neurons and N2a neuroblastoma cells as an in vitro model of AD. Cortical neurons were incubated with ZL006 or dimethyl sulfoxide for 2 hours and treated with Aβ1-42 or NH3*H2O for another 24 hours. The results of cell counting Kit-8 (CCK-8) assay and calcein-acetoxymethylester/propidium iodide staining showed that ZL006 pretreatment rescued the neuronal death induced by Aβ1-42. Fluorescence and western blot assay were used to detect oxidative stress and apoptosis-related proteins in each group of cells. Results showed that ZL006 pretreatment decreased neuronal apoptosis and oxidative stress induced by Aβ1-42. The results of CCK8 assay showed that inhibition of Akt or NF-E2-related factor 2 (Nrf2) in cortical neurons abolished the protective effects of ZL006. Moreover, similar results were also observed in N2a neuroblastoma cells. ZL006 inhibited N2a cell death and oxidative stress induced by Aβ1-42, while inhibition of Akt or Nrf2 abolished the protective effect of ZL006. These results demonstrated that ZL006 reduced Aβ1-42-induced neuronal damage and oxidative stress, and the mechanisms might be associated with the activation of Akt/Nrf2/heme oxygenase-1 signaling pathways.</description><identifier>ISSN: 1673-5374</identifier><identifier>EISSN: 1876-7958</identifier><identifier>DOI: 10.4103/1673-5374.285006</identifier><identifier>PMID: 32594052</identifier><language>eng</language><publisher>Mumbai: Wolters Kluwer India Pvt. Ltd</publisher><subject>akt; alzheimer’s disease; amyloid-beta; apoptosis; heme oxygenase-1; neurotoxicity; nrf2; oxidative stress; treatment; zl006 ; Apoptosis ; Membranes ; Neuroblastoma ; Oxidative stress ; Polyclonal antibodies ; Proteins</subject><ispartof>Neural regeneration research, 2020-12, Vol.15 (12), p.2296-2305</ispartof><rights>2020. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright © Wanfang Data Co. Ltd. All Rights Reserved.</rights><rights>Copyright: © 2020 Neural Regeneration Research 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://www.wanfangdata.com.cn/images/PeriodicalImages/zgsjzsyj-e/zgsjzsyj-e.jpg</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2417960990/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2417960990?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,44566,53766,53768,74869</link.rule.ids></links><search><creatorcontrib>Tao, Wen-Yuan</creatorcontrib><creatorcontrib>Yu, Lin-Jie</creatorcontrib><creatorcontrib>Jiang, Su</creatorcontrib><creatorcontrib>Cao, Xiang</creatorcontrib><creatorcontrib>Chen, Jian</creatorcontrib><creatorcontrib>Bao, Xin-Yu</creatorcontrib><creatorcontrib>Li, Fei</creatorcontrib><creatorcontrib>Xu, Yun</creatorcontrib><creatorcontrib>Zhu, Xiao-Lei</creatorcontrib><title>Neuroprotective effects of ZL006 in Aβ1-42-treated neuronal cells</title><title>Neural regeneration research</title><description>Amyloid beta (Aβ)-induced neurotoxicity and oxidative stress plays an important role in the pathogenesis of Alzheimer's disease (AD). ZL006 is shown to reduce over-produced nitric oxide and oxidative stress in ischemic stroke by interrupting the interaction of neuronal nitric oxide synthase and postsynaptic density protein 95. However, few studies are reported on the role of ZL006 in AD. To investigate whether ZL006 exerted neuroprotective effects in AD, we used Aβ1-42 to treat primary cortical neurons and N2a neuroblastoma cells as an in vitro model of AD. Cortical neurons were incubated with ZL006 or dimethyl sulfoxide for 2 hours and treated with Aβ1-42 or NH3*H2O for another 24 hours. The results of cell counting Kit-8 (CCK-8) assay and calcein-acetoxymethylester/propidium iodide staining showed that ZL006 pretreatment rescued the neuronal death induced by Aβ1-42. Fluorescence and western blot assay were used to detect oxidative stress and apoptosis-related proteins in each group of cells. Results showed that ZL006 pretreatment decreased neuronal apoptosis and oxidative stress induced by Aβ1-42. The results of CCK8 assay showed that inhibition of Akt or NF-E2-related factor 2 (Nrf2) in cortical neurons abolished the protective effects of ZL006. Moreover, similar results were also observed in N2a neuroblastoma cells. ZL006 inhibited N2a cell death and oxidative stress induced by Aβ1-42, while inhibition of Akt or Nrf2 abolished the protective effect of ZL006. These results demonstrated that ZL006 reduced Aβ1-42-induced neuronal damage and oxidative stress, and the mechanisms might be associated with the activation of Akt/Nrf2/heme oxygenase-1 signaling pathways.</description><subject>akt; alzheimer’s disease; amyloid-beta; apoptosis; heme oxygenase-1; neurotoxicity; nrf2; oxidative stress; treatment; zl006</subject><subject>Apoptosis</subject><subject>Membranes</subject><subject>Neuroblastoma</subject><subject>Oxidative stress</subject><subject>Polyclonal antibodies</subject><subject>Proteins</subject><issn>1673-5374</issn><issn>1876-7958</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpVkU1v1DAQhi0EoqVw5xiJI0oZf8cXpLLio9KqXNoLF8vrjJekabzYSVftz-KH8JvwstuinmY0H8-8mpeQtxROBQX-gSrNa8m1OGWNBFDPyDFttKq1kc3zkj-0j8irnHsA2RjGX5IjzqQRINkx-XSBc4qbFCf0U3eLFYZQslzFUP1YFmTVjdXZn9-0FqyeEroJ22rc7YxuqDwOQ35NXgQ3ZHxziCfk6svny8W3evn96_nibFm3QstYC6fbgAiNcELp0LqGrYxiEkxgSnGtAwCuwEnqBF9xz01jwIsAofVCScpPyPme20bX203qbly6s9F19l8hprV1aer8gFZ4BkwZ7gOVgqIzgXrXaqq4wdb4UFgf96zNvLrB1uM4JTc8gT7tjN1Pu463VmthhIICeL8HbN0Y3Li2fZxTeUm29-vc3-e73mLRAHQnpEy_O5xL8deMefo_zgTVRoExO-biwIzDhClfD_MWky0qrse4tRTsznT76Krdm24ZM8o--Mj_Am6hobA</recordid><startdate>20201201</startdate><enddate>20201201</enddate><creator>Tao, Wen-Yuan</creator><creator>Yu, Lin-Jie</creator><creator>Jiang, Su</creator><creator>Cao, Xiang</creator><creator>Chen, Jian</creator><creator>Bao, Xin-Yu</creator><creator>Li, Fei</creator><creator>Xu, Yun</creator><creator>Zhu, Xiao-Lei</creator><general>Wolters Kluwer India Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt. Ltd</general><general>The State Key Laboratory of Pharmaceutical Biotechnology,Nanjing University,Nanjing,Jiangsu Province,China</general><general>Department of Neurology,Drum Tower Hospital,Medical School of Nanjing University,Nanjing,Jiangsu Province,China</general><general>Jiangsu Key Laboratory for Molecular Medicine,Nanjing,Jiangsu Province,China 4 Taizhou People's Hospital,Taizhou,Jiangsu Province,China%Department of Medicinal Chemistry,School of Pharmacy,Nanjing Medical University,Nanjing,Jiangsu Province,China</general><general>Wolters Kluwer - Medknow</general><general>Wolters Kluwer Medknow Publications</general><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M2M</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>2B.</scope><scope>4A8</scope><scope>92I</scope><scope>93N</scope><scope>PSX</scope><scope>TCJ</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20201201</creationdate><title>Neuroprotective effects of ZL006 in Aβ1-42-treated neuronal cells</title><author>Tao, Wen-Yuan ; Yu, Lin-Jie ; Jiang, Su ; Cao, Xiang ; Chen, Jian ; Bao, Xin-Yu ; Li, Fei ; Xu, Yun ; Zhu, Xiao-Lei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-d475o-4a7dfee084a467fda82b962509f266377f00eb0a51a43b3c39890c4f0fdc46513</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>akt; alzheimer’s disease; amyloid-beta; apoptosis; heme oxygenase-1; neurotoxicity; nrf2; oxidative stress; treatment; zl006</topic><topic>Apoptosis</topic><topic>Membranes</topic><topic>Neuroblastoma</topic><topic>Oxidative stress</topic><topic>Polyclonal antibodies</topic><topic>Proteins</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tao, Wen-Yuan</creatorcontrib><creatorcontrib>Yu, Lin-Jie</creatorcontrib><creatorcontrib>Jiang, Su</creatorcontrib><creatorcontrib>Cao, Xiang</creatorcontrib><creatorcontrib>Chen, Jian</creatorcontrib><creatorcontrib>Bao, Xin-Yu</creatorcontrib><creatorcontrib>Li, Fei</creatorcontrib><creatorcontrib>Xu, Yun</creatorcontrib><creatorcontrib>Zhu, Xiao-Lei</creatorcontrib><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Psychology Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>Wanfang Data Journals - Hong Kong</collection><collection>WANFANG Data Centre</collection><collection>Wanfang Data Journals</collection><collection>万方数据期刊 - 香港版</collection><collection>China Online Journals (COJ)</collection><collection>China Online Journals (COJ)</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Neural regeneration research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tao, Wen-Yuan</au><au>Yu, Lin-Jie</au><au>Jiang, Su</au><au>Cao, Xiang</au><au>Chen, Jian</au><au>Bao, Xin-Yu</au><au>Li, Fei</au><au>Xu, Yun</au><au>Zhu, Xiao-Lei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuroprotective effects of ZL006 in Aβ1-42-treated neuronal cells</atitle><jtitle>Neural regeneration research</jtitle><date>2020-12-01</date><risdate>2020</risdate><volume>15</volume><issue>12</issue><spage>2296</spage><epage>2305</epage><pages>2296-2305</pages><issn>1673-5374</issn><eissn>1876-7958</eissn><abstract>Amyloid beta (Aβ)-induced neurotoxicity and oxidative stress plays an important role in the pathogenesis of Alzheimer's disease (AD). ZL006 is shown to reduce over-produced nitric oxide and oxidative stress in ischemic stroke by interrupting the interaction of neuronal nitric oxide synthase and postsynaptic density protein 95. However, few studies are reported on the role of ZL006 in AD. To investigate whether ZL006 exerted neuroprotective effects in AD, we used Aβ1-42 to treat primary cortical neurons and N2a neuroblastoma cells as an in vitro model of AD. Cortical neurons were incubated with ZL006 or dimethyl sulfoxide for 2 hours and treated with Aβ1-42 or NH3*H2O for another 24 hours. The results of cell counting Kit-8 (CCK-8) assay and calcein-acetoxymethylester/propidium iodide staining showed that ZL006 pretreatment rescued the neuronal death induced by Aβ1-42. Fluorescence and western blot assay were used to detect oxidative stress and apoptosis-related proteins in each group of cells. Results showed that ZL006 pretreatment decreased neuronal apoptosis and oxidative stress induced by Aβ1-42. The results of CCK8 assay showed that inhibition of Akt or NF-E2-related factor 2 (Nrf2) in cortical neurons abolished the protective effects of ZL006. Moreover, similar results were also observed in N2a neuroblastoma cells. ZL006 inhibited N2a cell death and oxidative stress induced by Aβ1-42, while inhibition of Akt or Nrf2 abolished the protective effect of ZL006. These results demonstrated that ZL006 reduced Aβ1-42-induced neuronal damage and oxidative stress, and the mechanisms might be associated with the activation of Akt/Nrf2/heme oxygenase-1 signaling pathways.</abstract><cop>Mumbai</cop><pub>Wolters Kluwer India Pvt. Ltd</pub><pmid>32594052</pmid><doi>10.4103/1673-5374.285006</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1673-5374
ispartof Neural regeneration research, 2020-12, Vol.15 (12), p.2296-2305
issn 1673-5374
1876-7958
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_4c202693cf1541ea9f1cad71639ed9cf
source Publicly Available Content Database; PubMed Central
subjects akt
alzheimer’s disease
amyloid-beta
apoptosis
heme oxygenase-1
neurotoxicity
nrf2
oxidative stress
treatment
zl006
Apoptosis
Membranes
Neuroblastoma
Oxidative stress
Polyclonal antibodies
Proteins
title Neuroprotective effects of ZL006 in Aβ1-42-treated neuronal cells
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T10%3A00%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wanfang_jour_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuroprotective%20effects%20of%20ZL006%20in%20A%CE%B21-42-treated%20neuronal%20cells&rft.jtitle=Neural%20regeneration%20research&rft.au=Tao,%20Wen-Yuan&rft.date=2020-12-01&rft.volume=15&rft.issue=12&rft.spage=2296&rft.epage=2305&rft.pages=2296-2305&rft.issn=1673-5374&rft.eissn=1876-7958&rft_id=info:doi/10.4103/1673-5374.285006&rft_dat=%3Cwanfang_jour_doaj_%3Ezgsjzsyj_e202012026%3C/wanfang_jour_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-d475o-4a7dfee084a467fda82b962509f266377f00eb0a51a43b3c39890c4f0fdc46513%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2417960990&rft_id=info:pmid/32594052&rft_wanfj_id=zgsjzsyj_e202012026&rfr_iscdi=true